戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 d upregulated in oligodendrocytes during RGC axon regeneration.
2 al activation, with very limited spontaneous axon regeneration.
3 K3beta, as both GSK3(S/A) knock-ins improved axon regeneration.
4 ownstream effector of GSK3beta in regulating axon regeneration.
5 red C. elegans GABA motor neurons to enhance axon regeneration.
6 cant spontaneous axonal sprouting instead of axon regeneration.
7 y and chemically inhibitory scar that limits axon regeneration.
8 ensive view of the complex biology governing axon regeneration.
9 nockdown of Lrig2 significantly improves CNS axon regeneration.
10 onditional knock out in vivo impairs sensory axon regeneration.
11  limits their utility for assessments of CST axon regeneration.
12 nd growth cone re-formation are required for axon regeneration.
13  scar and poor axon growth potential prevent axon regeneration.
14  of the intrinsic elongating form of sensory axon regeneration.
15 tify PARP1 as an effective target to promote axon regeneration.
16 injured neurons and contributes to stimulate axon regeneration.
17 l deficits due to the absence of spontaneous axon regeneration.
18 keleton that are prerequisites for effective axon regeneration.
19 rminal phosphate cyclase) as an inhibitor of axon regeneration.
20  and suggests hypoxia as a tool to stimulate axon regeneration.
21  may have therapeutic potential in promoting axon regeneration.
22 promoting retinal ganglion cell survival and axon regeneration.
23  NG2+ cells is an additional obstacle to CNS axon regeneration.
24 ulated by mTOR in injured neurons to promote axon regeneration.
25 t 4E-BP inhibition, is sufficient to promote axon regeneration.
26 y hostile environment and further inhibiting axon regeneration.
27 ivate intrinsic signaling pathways to enable axon regeneration.
28  4E-BP is required for PTEN deletion-induced axon regeneration.
29 al elongation and forming potent barriers to axon regeneration.
30 RSKS-1 as a new cell-autonomous inhibitor of axon regeneration.
31 athways, and the role of stress in promoting axon regeneration.
32  and leads to enhanced retinal ganglion cell axon regeneration.
33 owth-inert retraction bulbs and facilitating axon regeneration.
34 d Sox11 as one that could induce substantial axon regeneration.
35  modulates growth cone actin dynamics during axon regeneration.
36 portant in sealing the lesion and inhibiting axon regeneration.
37  a potential therapeutic strategy to enhance axon regeneration.
38 y progressing growth cones is a major aim in axon regeneration.
39 linical investigations to promote functional axon regeneration.
40  these cell types might be key inhibitors of axon regeneration.
41 models of dorsal root ganglion neuron (DRGN) axon regeneration.
42 have been few direct analyses of age-related axon regeneration.
43 DAC5 as a transcriptional switch controlling axon regeneration.
44 nd that PI3K pathway is required for sensory axon regeneration.
45 ortant for providing a permissive bridge for axon regeneration.
46 ical treatment with 7,8 DHF had no effect on axon regeneration.
47 gnaling between SCs and axons for successful axon regeneration.
48 ecline in anterior ventral microtubule (AVM) axon regeneration.
49 survival, migration, and polarity as well as axon regeneration.
50  PTEN-Akt pathway that is also important for axon regeneration.
51 ) are regulators of synaptic development and axon regeneration.
52 hnRNP K that is essential for successful CNS axon regeneration.
53 elicits profound cellular changes, including axon regeneration.
54 se that results in a dense scar that impedes axon regeneration.
55 Cs) survive with relatively high spontaneous axon regeneration.
56 f tubulin modifications that is required for axon regeneration.
57 tegy for identifying conserved mechanisms of axon regeneration.
58 n essential role in growth cone dynamics and axon regeneration.
59 ormation of this "glial bridge" and prevents axon regeneration.
60 -induced retrograde axonal degeneration, and axon regeneration.
61 ors is insufficient to trigger long-distance axon regeneration.
62 l nervous system is incapable of restorative axon regeneration.
63 omponents as effective targets for promoting axon regeneration.
64 dulation of BMP signaling influences sensory axon regeneration.
65 h a possible role of NFs in the mechanism of axon regeneration.
66 ys must be coordinately activated to promote axon regeneration.
67 r the role of c-Jun in regulation of in vivo axon regeneration.
68 that act synergistically to promote enhanced axon regeneration.
69 ecular mechanisms within neurons that govern axon regeneration.
70 ry creates physical and chemical barriers to axon regeneration.
71 ke Factor) family RBP UNC-75 is required for axon regeneration.
72 e inhibitory properties of the glial scar in axon regeneration.
73 e activation of GSK3beta reduces AKT-induced axon regeneration.
74 es both GSK3beta and AKT-mediated effects on axon regeneration.
75 ich mTORC2 and pAKT-S473 negatively regulate axon regeneration.
76 ion of eIF2Bepsilon is sufficient to promote axon regeneration.
77 F and RhoGAP, respectively, as regulators of axon regeneration.
78 onal cues to create a supportive pathway for axon regeneration.
79 tive and negative cues to regulate adult CNS axon regeneration.
80 s) in post-transcriptional regulation during axon regeneration.
81  and that Celf2 mutant mice are defective in axon regeneration.
82  reconcile conflicting data on GSK3-mediated axon regeneration.
83 that chemical inhibition of PARPs can elicit axon regeneration.
84 o critical parallel pathways for AKT-induced axon regeneration.
85 ion of neuronal polarity is not required for axon regeneration.
86 erve injury, mitochondrial localization, and axon regeneration.
87  rather than prevents central nervous system axon regeneration.
88 r kinase 1 (DLK-1), a conserved regulator of axon regeneration.
89  and PARGs mediate DLK function in enhancing axon regeneration.
90  indispensable role in mediating AKT-induced axon regeneration.
91 neurons, Caenorhabditis elegans neurons lose axon regeneration ability as they age, but it is not kno
92  a novel mechanism for controlling intrinsic axon regeneration ability.
93 heathing glia (OEG) transplantation promotes axon regeneration across a complete spinal cord transect
94 thway, that poly-(ADP ribosylation) inhibits axon regeneration across species, and that chemical inhi
95 nglion neurons to express kindlin-1 promoted axon regeneration across the dorsal root entry zone and
96            Available strategies of promoting axon regeneration act on only some of these types.
97                                     Enabling axon regeneration after central nervous system (CNS) inj
98                                   Failure of axon regeneration after central nervous system (CNS) inj
99  as a novel therapeutic target for promoting axon regeneration after CNS injury.
100 le of mitochondrial transport for successful axon regeneration after injury and provide new insights
101 on growth during CNS development, as well as axon regeneration after injury in the peripheral nervous
102 lar membranes promoted adult rat optic nerve axon regeneration after injury in vivo.
103                                              Axon regeneration after injury requires the extensive re
104 cx1 also promotes both neuronal survival and axon regeneration after injury, and these effects depend
105 ht be targeted to enhance integrin-dependent axon regeneration after injury.
106 one directive molecules known for inhibiting axon regeneration after injury.
107 we show that RtcB acts in neurons to inhibit axon regeneration after nerve injury.
108  kindlin-1 is a potential tool for improving axon regeneration after nervous system lesions.
109  its function promoted retinal ganglion cell axon regeneration after optic nerve crush in mice.
110 or 9 (KLF9) via shRNA promotes long-distance axon regeneration after optic nerve injury and uncover a
111 r injury, promotes dramatic RGC survival and axon regeneration after optic nerve injury.
112 trophic factors to enhance cell survival and axon regeneration after optic nerve injury.
113 ay in retinal ganglion cells (RGCs) promotes axon regeneration after optic nerve injury.
114 ganglioside Ab with GD1a reactivity inhibits axon regeneration after PNS injury in an animal model.
115                                              Axon regeneration after spinal cord injury (SCI) fails d
116                                              Axon regeneration after spinal cord injury (SCI) fails d
117 ults in functional improvements and promotes axon regeneration after spinal cord injury.
118 ortive environment for neuronal survival and axon regeneration after spinal cord injury.
119  while DCXs synergize with mTOR to stimulate axon regeneration, alone they can promote neuronal survi
120        Moreover, those da neurons capable of axon regeneration also display dendrite regeneration, wh
121 ntrol of the neurite outgrowth length in our axon regeneration analysis.
122 itical extrinsic and intrinsic regulators of axon regeneration and establishes shRNA as a viable mean
123 n, protect tissue around the lesion, support axon regeneration and form myelin.
124                                Nogo-A limits axon regeneration and functional recovery after central
125 s their potential implications for promoting axon regeneration and functional recovery after nerve in
126 ctivate a pro-regenerative program to enable axon regeneration and functional recovery.
127 generative transcriptional program to enable axon regeneration and functional recovery.
128 with parthenolidein vivomarkedly accelerated axon regeneration and functional recovery.
129 Inpp5f (Sac2) leads to robust enhancement of axon regeneration and growth cone reformation.
130 ates had not previously been associated with axon regeneration and implicate new pathways of interest
131 gether, these drug-elicited effects promoted axon regeneration and improved motor function after SCI.
132 that anti-GD1a Abs can mediate inhibition of axon regeneration and limit recovery in some patients wi
133  either small-molecule trkB agonist enhanced axon regeneration and muscle reinnervation after periphe
134 iate, reverting to a phenotype that supports axon regeneration and nerve repair.
135 ormation in the lesion site that facilitated axon regeneration and neuron preservation.
136 R tip concentration was observed only during axon regeneration and not during dendrite regeneration.
137 iscusses possible strategies for stimulating axon regeneration and perhaps functional recovery after
138  IL-10-null mice was accompanied by impaired axon regeneration and poor recovery of motor and sensory
139 Furthermore, lack of IL-10 leads to impaired axon regeneration and poor recovery of motor and sensory
140 ter peripheral nerve injury is essential for axon regeneration and recovery.
141 ing a nonpermissive environment that impairs axon regeneration and remyelination.
142 ation, downstream of Pten deletion, promotes axon regeneration and RGC survival.
143 roRNA-138 (miR-138) as a novel suppressor of axon regeneration and show that SIRT1, the NAD-dependent
144 esults also underline the key role of SCs in axon regeneration and successful target reinnervation.SI
145 ulation of integrins is a route to promoting axon regeneration and understanding regeneration failure
146 athway regulates nervous system development, axon regeneration, and neuronal degeneration after acute
147 anism selectively contributing to myelinated axon regeneration, and point out the role of Cl(-) modul
148 TOR can serve as powerful tool for enhancing axon regeneration, and they highlight the remarkable cap
149 tes, however, are capable of spontaneous CNS axon regeneration, and we have shown that retinal gangli
150 death, scarring, and a failure of tissue and axon regeneration are not ameliorated by current treatme
151 ene expression, but their roles in mammalian axon regeneration are not well explored.
152            Implications of GSK3 activity for axon regeneration are often inconsistent, if not controv
153                    Stroked eyes showed minor axon regeneration around the optic nerve lesion site at
154                            Human SCs support axon regeneration as do rat SCs.
155 ce suggests that reduced levels could impair axon regeneration as well as axon survival in aging and
156         HDAC5 nuclear export is required for axon regeneration, as expression of a nuclear-trapped HD
157   While traditionally viewed as a barrier to axon regeneration, beneficial functions of the glial sca
158      Combinatorial treatment generated motor axon regeneration beyond both C5 hemisection and T3 comp
159 ased peripheral conditioning-lesion-enhanced axon regeneration beyond the epicenter.
160 tubulin deacetylation, which is required for axon regeneration both in vitro and in vivo.
161  (CSPGs) found within the glial scar inhibit axon regeneration but the intracellular signaling mechan
162             Signaling pathways essential for axon regeneration, but not for neuron development or fun
163 cell-intrinsic and extrinsic pathways govern axon regeneration, but only a limited number of factors
164 iated activation of 5-HT signalling promotes axon regeneration by activating both the RhoA and cAMP p
165                          SER-7 also promotes axon regeneration by activating the cyclic AMP (cAMP) si
166  factor, and that 5-HT subsequently promotes axon regeneration by autocrine signalling through the SE
167 he HSP proteins spastin and atlastin promote axon regeneration by coordinating concentration of the E
168 ta are well positioned to regulate intrinsic axon regeneration capacity, which declines developmental
169  phases of nerve repair, resulting in slowed axon regeneration, cutaneous reinnervation, and function
170 th in mammals can be effectively reduced and axon regeneration enhanced over the short term.
171                                              Axon regeneration fails if the activity of either pathwa
172                                              Axon regeneration fails in the adult CNS, resulting in p
173 nal program is a critical step in successful axon regeneration following injury.
174 r remyelination, macrophage recruitment, and axon regeneration following nerve injury.
175                           The probability of axon regeneration for individual identified neurons was
176 odels of SCI, we report robust corticospinal axon regeneration, functional synapse formation and impr
177                     The factors that control axon regeneration have been examined in many systems, bu
178 ress made in understanding the mechanisms of axon regeneration, how a neuron responds to an injury an
179 tegrins can overcome inhibition and increase axon regeneration, however integrins are not transported
180 pulsive guidance responses and inhibition of axon regeneration; however, the cytoskeletal mechanisms
181 S6K1 decrease the effect of PTEN deletion on axon regeneration, implicating a dual role of S6K1 in re
182 t reduction of spastin leads to a deficit in axon regeneration in a Drosophila model.
183 on of multiple RAGs and promotion of sensory axon regeneration in a mouse model of spinal cord injury
184 vely in adult DRG neurons results in sensory axon regeneration in a mouse model of spinal cord injury
185 pathways as key for sustaining long-distance axon regeneration in adult CNS, a crucial step towards f
186  of alpha9 integrin and kindlin-1 on sensory axon regeneration in adult rat spinal cord after dorsal
187                            Here we show that axon regeneration in aging C. elegans motor neurons is i
188                        Factors that regulate axon regeneration in C. elegans have broadly similar rol
189                  To identify genes affecting axon regeneration in Caenorhabditis elegans, we performe
190 onverted GD1a ganglioside to GM1 and rescued axon regeneration in CNS axons and in PNS axons after Ne
191 d neuron-derived BDNF are thus important for axon regeneration in cut peripheral nerves.
192 r, others have demonstrated mTOR-independent axon regeneration in different cell types, raising the q
193 , and deficiency of Archease or Xbp1 impeded axon regeneration in Drosophila.
194 evelopmental axon growth may also facilitate axon regeneration in injured adult neurons.
195 nomous defects in macrophage recruitment and axon regeneration in injured nerves following loss of Gp
196  potential therapeutic approaches to promote axon regeneration in injury and other degenerative disea
197  mechanisms of neuronal injury responses and axon regeneration in mammals.
198 rently lack a therapy that potently enhances axon regeneration in patients with traumatic nerve injur
199  wild Antheraea pernyi silkworms can support axon regeneration in peripheral nerve injury.
200 s with age, yet the mechanisms that regulate axon regeneration in response to age are not known.
201 elongation in hippocampal neurons as well as axon regeneration in sensory neurons.
202 uggest new therapeutic strategies to promote axon regeneration in the adult CNS.SIGNIFICANCE STATEMEN
203 -eIF2Bepsilon signaling module in regulating axon regeneration in the adult mammalian CNS.
204 emoved by active DNA demethylation to permit axon regeneration in the adult mammalian nervous system.
205                                              Axon regeneration in the central nervous system normally
206                                              Axon regeneration in the CNS requires reactivating injur
207 CNS, and activating the Akt pathway enhances axon regeneration in the CNS.
208 ckdown undermines both neuronal survival and axon regeneration in the high regenerative capacity mode
209                                              Axon regeneration in the injured adult CNS is reportedly
210 tified gene expression patterns and promotes axon regeneration in the injured adult mouse CNS, demons
211 l ganglion cells from apoptosis and promotes axon regeneration in the injured optic nerve.
212 thesis might be involved in the mechanism of axon regeneration in the lamprey spinal cord.
213  the presence of Nogo-A does not inhibit RGC axon regeneration in the lizard visual pathway.
214 protein Nogo-A contributes to the failure of axon regeneration in the mammalian central nervous syste
215                    Overcoming the failure of axon regeneration in the mammalian central nervous syste
216 protein Nogo-A contributes to the failure of axon regeneration in the mammalian central nervous syste
217 ng as a central module for promoting sensory axon regeneration in the mammalian nervous system.
218 h ability is the major reason for the failed axon regeneration in the mature mammalian CNS.
219  describes current progress in understanding axon regeneration in the model organism Caenorhabditis e
220 one machinery as a novel strategy to promote axon regeneration in the nervous system after injury.
221 hila CNS, whereas its overexpression reduced axon regeneration in the periphery.
222 lay a key role in spontaneous lizard retinal axon regeneration in the presence of Nogo-A.
223 ce demonstrated a 2-fold increase in sensory axon regeneration in the spinal cord in comparison to wi
224                                   Studies of axon regeneration in the spinal cord often assess regene
225 ture of the mechanisms behind successful CNS axon regeneration in this vertebrate model organism.
226 oth an RNAi-based screen for defective motor axon regeneration in unc-70/beta-spectrin mutants and a
227 duction of HIF-1alpha using hypoxia enhances axon regeneration in vitro and in vivo in sensory neuron
228 reas enhancing HDAC5 nuclear export promotes axon regeneration in vitro and in vivo.
229 n4b seems to represent no major obstacle for axon regeneration in vivo because it is less inhibitory
230 ngs identify a unique means of promoting CST axon regeneration in vivo by reengineering a development
231 ite growth suppression in vitro and promoted axon regeneration in vivo These findings demonstrate a n
232 nd neuronal viability in vitro and restricts axon regeneration in vivo, and demonstrate a novel, non-
233 ce that miR-138 and SIRT1 regulate mammalian axon regeneration in vivo.
234 te depletion of Smad1 in adult mice prevents axon regeneration in vivo.
235  inhibitory activity of CSPGs and stimulated axon regeneration in vivo.
236 role for the Notch pathway as a repressor of axon regeneration in vivo.
237           DLK KO axons have severely reduced axon regeneration in vivo.
238 review focuses on recent advances in sensory axon regeneration, including studies assessing the abili
239 eletion or inactivation of GSK3beta promotes axon regeneration independently of the mTORC1 pathway, w
240  RGCs to block AIS reassembly did not affect axon regeneration, indicating that preservation of neuro
241        Significance statement: The extent of axon regeneration is a critical determinant of neurologi
242                                              Axon regeneration is a medically relevant process that c
243 ture cortical neurons, Nogo-22 inhibition of axon regeneration is abolished by genetic deletion of Ng
244                                   Peripheral axon regeneration is accelerated by prior injury; howeve
245                                              Axon regeneration is an essential process to rebuild fun
246                            After CNS injury, axon regeneration is blocked by an inhibitory environmen
247               Thus, a sustained capacity for axon regeneration is critical for achieving functional r
248                                              Axon regeneration is essential to restore the nervous sy
249 dentified and it is not clear to what extent axon regeneration is evolutionarily conserved.
250                                              Axon regeneration is hindered by a decline of intrinsic
251  the critical processes of neurodegeneration/axon regeneration is incompletely understood.
252 er, the neuronal cell biology that underlies axon regeneration is incompletely understood.
253                   Furthermore, inhibition of axon regeneration is independent of the RtcB cofactor ar
254      This reciprocal inhibition ensures that axon regeneration is inhibited only in older neurons.
255       Understanding the mechanism underlying axon regeneration is of great practical importance for d
256                       In the absence of TTL, axon regeneration is reduced severely.
257                             A determinant of axon regeneration is the intrinsic growth ability of inj
258 ment, a major limiting factor for successful axon regeneration is the poor intrinsic regenerative cap
259  trkB is knocked out selectively in neurons, axon regeneration is very weak, and topical treatment wi
260 rfering CASP2-mediated retinal ganglion cell axon regeneration, Muller cell activation and CNTF produ
261         The deletion of KLF4 in vivo induces axon regeneration of adult retinal ganglion cells (RGCs)
262 ch add poly(ADP-ribose) to proteins, inhibit axon regeneration of both C. elegans GABA neurons and ma
263    Functionally, Tet3 is required for robust axon regeneration of DRG neurons and behavioral recovery
264                   Moreover, Nogo-22 inhibits axon regeneration of mature cortical neurons in vitro mo
265           In addition, Pten deletion-induced axon regeneration of retinal ganglion neurons in the adu
266      Severe motoneuron death and inefficient axon regeneration often result in devastating motor dysf
267 on associated with Wallerian degeneration or axon regeneration or the clearance of myelin debris by m
268 oves intrinsic growth potential to result in axon regeneration out of a growth-supportive peripheral
269 tudy demonstrates that long-distance sensory axon regeneration over a normal pathway and with sensory
270 r genetic loss of PARP1 markedly facilitates axon regeneration over nonpermissive substrates.
271 e, we identify novel intrinsic regulators of axon regeneration: poly(ADP-ribose) glycohodrolases (PAR
272                   We therefore conclude that axon regeneration promoted by suppression of CASP2 and C
273  by down-regulating LIN-41, an important AVM axon regeneration-promoting factor.
274 transmission that doubles as a suppressor of axon regeneration, providing a molecular clue for the sy
275  the growth potential and induce spontaneous axon regeneration remain poorly understood.
276 ury responses, such as neuronal survival and axon regeneration, remain largely unknown.
277 le ZMB provides a novel context for studying axon regeneration, Schwann cell migration, and remyelina
278       Expression of alpha9 integrin promotes axon regeneration, so we have investigated alpha9beta1 t
279 8 months after injury demonstrated that this axon regeneration suppressed locomotor performance and d
280 oform in CNS, AKT3, induces much more robust axon regeneration than AKT1 and that activation of mTORC
281 ection of the cross-regulating mechanisms in axon regeneration that involve the downstream effectors
282 LF4 and activated STAT3 in the regulation of axon regeneration that might have therapeutic implicatio
283  the negative regulator of PI3K, induces CNS axon regeneration through the activation of PI3K-mTOR si
284                         Our study thus links axon regeneration to cellular stress and RNA metabolism,
285 ole for active DNA demethylation in allowing axon regeneration to occur in the mature nervous system
286 nt state with little axonal growth to robust axon regeneration upon injury.
287                                              Axon regeneration was enhanced when the fibrin glue cont
288                                              Axon regeneration was similarly impaired in neurons when
289 rstand genetic determinants of mammalian CNS axon regeneration, we completed an unbiased RNAi gene-si
290    In an established mouse model with robust axon regeneration, we show that Armcx1, a mammalian-spec
291        Extending these findings to mammalian axon regeneration, we show that mouse Celf2 expression i
292 tinal ganglion cell (RGC) loss and extent of axon regeneration were determined at 8 and 14 days after
293 roglia depletion, spontaneous and LI-induced axon regeneration were unaffected by PLX5622 treatment o
294 urthermore, chemical PARP inhibitors improve axon regeneration when administered after injury.
295 ctive therapeutic strategy for promoting CNS axon regeneration when combined with neurotrophic factor
296 n of a nuclear-trapped HDAC5 mutant prevents axon regeneration, whereas enhancing HDAC5 nuclear expor
297 wing spinal cord injury is due to failure of axon regeneration, which has been ascribed to environmen
298 types, such as the maintenance of memory and axon regeneration with age, in both mammals and C. elega
299 fully enhance the repair capacity of SCs and axon regeneration, without substantial off-target damage
300 aling that drives both neurodegeneration and axon regeneration, yet little is known about the factors

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top